Trial Outcomes & Findings for Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain? (NCT NCT01070771)
NCT ID: NCT01070771
Last Updated: 2019-05-22
Results Overview
This outcome measure was assessing agreement in the management plan (MP) derived from angiographic assessment alone compared to a MP derived from angiographic assessment plus the use of FFR data acquired at the time of angiography. The study assessed the proportion of cases in which the angiogram directed MP changed after FFR data were disclosed.
COMPLETED
NA
203 participants
Up until hospital discharge. Most cases were day cases but no specific data relating to length of stay collected.
2019-05-22
Participant Flow
Participant milestones
| Measure |
Radi Pressure Wire
Assessment of physiological significance of coronary artery narrowings by measurement of blood flow limitation across lesion.
|
|---|---|
|
Overall Study
STARTED
|
203
|
|
Overall Study
COMPLETED
|
200
|
|
Overall Study
NOT COMPLETED
|
3
|
Reasons for withdrawal
| Measure |
Radi Pressure Wire
Assessment of physiological significance of coronary artery narrowings by measurement of blood flow limitation across lesion.
|
|---|---|
|
Overall Study
Adverse Event
|
2
|
|
Overall Study
Protocol Violation
|
1
|
Baseline Characteristics
Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain?
Baseline characteristics by cohort
| Measure |
Radi Pressure Wire
n=200 Participants
|
|---|---|
|
Age, Continuous
|
64 years
STANDARD_DEVIATION 10 • n=5 Participants
|
|
Sex: Female, Male
Female
|
51 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
149 Participants
n=5 Participants
|
|
Region of Enrollment
United Kingdom
|
200 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Up until hospital discharge. Most cases were day cases but no specific data relating to length of stay collected.This outcome measure was assessing agreement in the management plan (MP) derived from angiographic assessment alone compared to a MP derived from angiographic assessment plus the use of FFR data acquired at the time of angiography. The study assessed the proportion of cases in which the angiogram directed MP changed after FFR data were disclosed.
Outcome measures
| Measure |
Radi Pressure Wire
n=200 Participants
|
|---|---|
|
Estimation of Number of Cases Where FFR Data Results in a Change in the Management Strategy (Number of Vessel Requiring Treatment and/or PCI vs Medical vs CABG)
Agreement with management plan
|
147 participants
|
|
Estimation of Number of Cases Where FFR Data Results in a Change in the Management Strategy (Number of Vessel Requiring Treatment and/or PCI vs Medical vs CABG)
Change in management plan after FFR
|
53 participants
|
|
Estimation of Number of Cases Where FFR Data Results in a Change in the Management Strategy (Number of Vessel Requiring Treatment and/or PCI vs Medical vs CABG)
Recommended medical treatment alone
|
72 participants
|
|
Estimation of Number of Cases Where FFR Data Results in a Change in the Management Strategy (Number of Vessel Requiring Treatment and/or PCI vs Medical vs CABG)
Revascularisation was advised after FFR
|
9 participants
|
|
Estimation of Number of Cases Where FFR Data Results in a Change in the Management Strategy (Number of Vessel Requiring Treatment and/or PCI vs Medical vs CABG)
Optimal medical therapy recommended after FFR
|
89 participants
|
|
Estimation of Number of Cases Where FFR Data Results in a Change in the Management Strategy (Number of Vessel Requiring Treatment and/or PCI vs Medical vs CABG)
Recommended revascularisation after angiogram
|
25 participants
|
|
Estimation of Number of Cases Where FFR Data Results in a Change in the Management Strategy (Number of Vessel Requiring Treatment and/or PCI vs Medical vs CABG)
Recommendation of PCI after angio assessment
|
90 participants
|
|
Estimation of Number of Cases Where FFR Data Results in a Change in the Management Strategy (Number of Vessel Requiring Treatment and/or PCI vs Medical vs CABG)
Of the 90 FFR detected no significant stenosis
|
24 participants
|
SECONDARY outcome
Timeframe: Up to hospital discharge. Most were day case procedures but no specific data relating to discharge was collected.This compared the number of vessels in which there was a discrepant result in relation to angiographically and FFR defined significance. Angiographic significance was visually assessed by operators whereas the pressure wire provided objective data as to a narrowing's significance: an FFR reading of \<0.8 indicated a significant restriction in blood flow with a recommendation for revascularisation. The difference in indication for revascularisation of each major coronary artery was also judged according to angiogram alone compared with angiogram plus FFR dtaa.
Outcome measures
| Measure |
Radi Pressure Wire
n=200 Participants
|
|---|---|
|
To Determine the Level of Agreement in Management Plans Regarding the Significance of Coronary Artery Narrowings When Comparing the MP Acquired by Standard Angiographic Assessment Alone and a MP Acquired Using Angiographic Assessment Plus FFR Data.
significant 3 vessel disease at angio:negative FFR
|
1 participants
|
|
To Determine the Level of Agreement in Management Plans Regarding the Significance of Coronary Artery Narrowings When Comparing the MP Acquired by Standard Angiographic Assessment Alone and a MP Acquired Using Angiographic Assessment Plus FFR Data.
Number of vessels significantly changed after FFR
|
64 participants
|
|
To Determine the Level of Agreement in Management Plans Regarding the Significance of Coronary Artery Narrowings When Comparing the MP Acquired by Standard Angiographic Assessment Alone and a MP Acquired Using Angiographic Assessment Plus FFR Data.
No significant CAD after angiography alone
|
81 participants
|
|
To Determine the Level of Agreement in Management Plans Regarding the Significance of Coronary Artery Narrowings When Comparing the MP Acquired by Standard Angiographic Assessment Alone and a MP Acquired Using Angiographic Assessment Plus FFR Data.
Of the 81, significant FFR (<0.8)
|
18 participants
|
|
To Determine the Level of Agreement in Management Plans Regarding the Significance of Coronary Artery Narrowings When Comparing the MP Acquired by Standard Angiographic Assessment Alone and a MP Acquired Using Angiographic Assessment Plus FFR Data.
No haemodynamically signifiacnt CAD after FFR
|
89 participants
|
|
To Determine the Level of Agreement in Management Plans Regarding the Significance of Coronary Artery Narrowings When Comparing the MP Acquired by Standard Angiographic Assessment Alone and a MP Acquired Using Angiographic Assessment Plus FFR Data.
Of the 89, angio labelled as single vessel disease
|
24 participants
|
|
To Determine the Level of Agreement in Management Plans Regarding the Significance of Coronary Artery Narrowings When Comparing the MP Acquired by Standard Angiographic Assessment Alone and a MP Acquired Using Angiographic Assessment Plus FFR Data.
of the 89, angio labelled as 2 vessel disease
|
1 participants
|
|
To Determine the Level of Agreement in Management Plans Regarding the Significance of Coronary Artery Narrowings When Comparing the MP Acquired by Standard Angiographic Assessment Alone and a MP Acquired Using Angiographic Assessment Plus FFR Data.
of the 89, angio labelled as 3 vessel disease
|
1 participants
|
Adverse Events
RADI Pressure Wire
Serious adverse events
| Measure |
RADI Pressure Wire
n=200 participants at risk
|
|---|---|
|
Cardiac disorders
Vessel occlusion
|
0.50%
1/200 • Number of events 1
Only serious adverse events were collected
|
|
Cardiac disorders
Coronary artery dissection
|
0.50%
1/200 • Number of events 1
Only serious adverse events were collected
|
|
Cardiac disorders
Ventricular fibrillation
|
0.50%
1/200 • Number of events 1
Only serious adverse events were collected
|
|
Vascular disorders
Deep vein thrombosis
|
0.50%
1/200 • Number of events 1
Only serious adverse events were collected
|
Other adverse events
Adverse event data not reported
Additional Information
Professor Nick Curzen
University Hospital Southampton NHS Foundation Trust
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: GT60